Brief: Redcare Pharmacy Expects Group Revenue To Grow 13% To 15% In 2026

Redcare Pharmacy NV

04/03/2026 05:35

March 4 (Reuters) - Redcare Pharmacy NV RDC.DE:

EQS-NEWS: REDCARE PHARMACY: STRONG GROWTH IN 2025 SURPASSING EUR 1BN IN RX REVENUE; ADJUSTED. EBITDA UP 72% YOY.

2025 EBIT IMPROVES TO EUR –28.5 MILLION, NET LOSS NARROWS TO EUR –39.4 MILLION

FY GROUP REVENUE INCREASED 24% YOY TO EUR 2.9BN.

GUIDANCE FOR 2026 IS 13% TO 15% GROUP REVENUE GROWTH AND AN ADJUSTED. EBITDA MARGIN OF AT LEAST 2.5%.

EXPECTS GROUP REVENUE TO GROW 13% TO 15% IN 2026

ACHIEVE AN ADJUSTED EBITDA MARGIN OF AT LEAST 2.5% IN 2026

ON TRACK TO ACHIEVE ADJUSTED EBITDA MARGIN OF MORE THAN 5% IN MID-TERM

2026 GUIDANCE RX REVENUE IN GERMANY IN EXCESS OF EUR 670 MILLION

2025 NET CASH FROM FINANCING ACTIVITIES EUR 111.3 MILLION ON CONVERTIBLE BOND ISSUANCE AND REPURCHASE

Source text: ID:nEQ6Zy1D6a

Further company coverage: RDC.DE

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))